View ValuationPremier Biomedical 将来の成長Future 基準チェック /06現在、 Premier Biomedicalの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Biotechs 収益成長25.2%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Jul 08Premier Graphene, Inc. Ships Advanced Graphene Suspension Samples to Global Leader in Essential MaterialsPremier Graphene, Inc. announced that it shipped HGI’s proprietary graphene suspension test samples to one of the largest essential materials companies in the world for use in concrete. This essential materials company is adding graphene samples to concrete to confirm the game changing improved qualities of this concrete as measured by HGI’s in-house tests. Premier Graphene Inc. has exclusive distribution rights in the United States for this high-quality, economically viable graphene, as well as all graphene colloids and graphene suspensions created by HGI. Cement is the essential ingredient of concrete. Concrete is made by combining water, cement and aggregates (such as sand and gravel) to make the most essential building material throughout the world. By adding the graphene suspension samples to the concrete mixture, the improved characteristics have the potential to universally change the characteristics of concrete by making concrete greener, stronger, while reducing curing time, increasing durability and reducing maintenance, resulting in a substantial reduction in concrete material costs. With almost 8,000 employees, with a dominant distribution system in North America including almost 800 operating locations, this worldwide leader in the aggregate and cement business presents an extraordinary opportunity for Premier and HGI. With over a century of operational expertise and a public market value exceeding $50 billion USD, Premier Graphene’s potential partner leads North America in sustainable construction materials, road contracting, and building products sales. This interest was prompted by the independent laboratory’s reported 32% increase in compression strength over standard concrete at 28 days. The laboratory tested concrete reduced concrete porosity, enhanced durability, while reducing the amount of cement and concrete used based on a ratio of concrete/square foot. The reduction of concrete using the concrete enhanced with HGI’s graphene has the potential to significantly reduce construction costs by reducing the ratio of cement in future hydraulic cement mixes. Graphene, renowned as one of the most valuable materials globally, holds promise across diverse applications including construction, medical fields, electric vehicle batteries, and environmental remediation. Several months ago, HGI Industrial Technologies, with assistance from Premier Graphene, initiated testing of HGI’s proprietary graphene suspensions designed to enhance cement's structural properties. Initial trials demonstrated a significant reduction in carbon emissions—up to 30% less compared to conventional cement—by incorporating graphene, which could potentially mitigate 5% of global carbon emissions linked to cement production. Moreover, in just seven days HGI’s proprietary graphene suspensions facilitated a 15% increase in compression strength over standard concrete, alongside reduced concrete porosity, enhancing durability. That disparity in strength over conventional concrete increased to 25.6% after 14 days and to 32% when tested after 28 days! After the results of the test were known, a special group consisting of the company’s top engineers within their divisions held an hour(s) long Zoom call meeting and presentation with top Premier Graphene personnel including President Pedro Mendez, CTO Gustavo Carreño and CMO Dr. Richard Goulding to discuss sales, marketing and distribution plans.お知らせ • Mar 08Premier Graphene, Inc. Appoints Gustavo Carreño as Chief Technology OfficerPremier Graphene Inc. announces the appointment of visionary industry leader, Gustavo Carreño, as its new Chief Technology Officer (CTO). Mr. Carreño is poised to steer the Company into a future defined by innovation and transformative growth. With a proven track record at the forefront of technology-driven business evolution, the newly appointed CTO is primed to facilitate Premier Graphene’s foray into construction, oil & gas, and graphene manufacturing sectors with great expertise and strategic foresight. His experience serving as Managing Director for the Middle East and North Africa regions at Black Argentum LLC and CEO of Opulence Group, makes Gustavo uniquely qualified for this position. In these pursuits he cultivated invaluable connections between the Middle East and Latin America, unlocking lucrative cross-border opportunities in the oil & gas, commodity trading, and real estate development realms. This experience further enriches his strategic perspective, enabling him to identify and capitalize on synergies between industries and drive sustainable growth for Premier Graphene. Gustavo’s experience in revolutionizing operations through tech modernization and strategic initiatives underscores his ability to navigate complex business landscapes and implement innovative solutions tailored to industry needs. As Premier Graphene embarks on a journey of innovation and growth, the appointment of Gustavo as the new CTO signals a bold step towards a future defined by limitless possibilities. Premier Graphene eagerly anticipates the transformative impact of his leadership, as he works tirelessly to bring technological innovations to existing hemp-based graphene production while helping to explore these new very promising fields.お知らせ • Jun 30Premier Biomedical, Inc. announced delayed 10-Q filingOn 06/29/2020, Premier Biomedical, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Premier Biomedical は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測OTCPK:BIEI - アナリストの将来予測と過去の財務データ ( )USD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/20190000N/A9/30/20190-100N/A6/30/20190-100N/A3/31/20190-100N/A12/31/20180000N/A9/30/20180-100N/A6/30/20180300N/A3/31/20180200N/A12/31/20170-4-1-1N/A9/30/20170-300N/A6/30/2017N/A-7-1-1N/A3/31/2017N/A-700N/A12/31/2016N/A-200N/A9/30/2016N/A-2-1-1N/A6/30/2016N/A-2-1-1N/A3/31/2016N/A-2-1-1N/A12/31/2015N/A-300N/A9/30/2015N/A-300N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: BIEIの予測収益成長が 貯蓄率 ( 3.5% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: BIEIの収益がUS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: BIEIの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: BIEIの収益がUS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: BIEIの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: BIEIの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/26 23:40終値2026/05/26 00:00収益2019/12/31年間収益2019/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Premier Biomedical, Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Jul 08Premier Graphene, Inc. Ships Advanced Graphene Suspension Samples to Global Leader in Essential MaterialsPremier Graphene, Inc. announced that it shipped HGI’s proprietary graphene suspension test samples to one of the largest essential materials companies in the world for use in concrete. This essential materials company is adding graphene samples to concrete to confirm the game changing improved qualities of this concrete as measured by HGI’s in-house tests. Premier Graphene Inc. has exclusive distribution rights in the United States for this high-quality, economically viable graphene, as well as all graphene colloids and graphene suspensions created by HGI. Cement is the essential ingredient of concrete. Concrete is made by combining water, cement and aggregates (such as sand and gravel) to make the most essential building material throughout the world. By adding the graphene suspension samples to the concrete mixture, the improved characteristics have the potential to universally change the characteristics of concrete by making concrete greener, stronger, while reducing curing time, increasing durability and reducing maintenance, resulting in a substantial reduction in concrete material costs. With almost 8,000 employees, with a dominant distribution system in North America including almost 800 operating locations, this worldwide leader in the aggregate and cement business presents an extraordinary opportunity for Premier and HGI. With over a century of operational expertise and a public market value exceeding $50 billion USD, Premier Graphene’s potential partner leads North America in sustainable construction materials, road contracting, and building products sales. This interest was prompted by the independent laboratory’s reported 32% increase in compression strength over standard concrete at 28 days. The laboratory tested concrete reduced concrete porosity, enhanced durability, while reducing the amount of cement and concrete used based on a ratio of concrete/square foot. The reduction of concrete using the concrete enhanced with HGI’s graphene has the potential to significantly reduce construction costs by reducing the ratio of cement in future hydraulic cement mixes. Graphene, renowned as one of the most valuable materials globally, holds promise across diverse applications including construction, medical fields, electric vehicle batteries, and environmental remediation. Several months ago, HGI Industrial Technologies, with assistance from Premier Graphene, initiated testing of HGI’s proprietary graphene suspensions designed to enhance cement's structural properties. Initial trials demonstrated a significant reduction in carbon emissions—up to 30% less compared to conventional cement—by incorporating graphene, which could potentially mitigate 5% of global carbon emissions linked to cement production. Moreover, in just seven days HGI’s proprietary graphene suspensions facilitated a 15% increase in compression strength over standard concrete, alongside reduced concrete porosity, enhancing durability. That disparity in strength over conventional concrete increased to 25.6% after 14 days and to 32% when tested after 28 days! After the results of the test were known, a special group consisting of the company’s top engineers within their divisions held an hour(s) long Zoom call meeting and presentation with top Premier Graphene personnel including President Pedro Mendez, CTO Gustavo Carreño and CMO Dr. Richard Goulding to discuss sales, marketing and distribution plans.
お知らせ • Mar 08Premier Graphene, Inc. Appoints Gustavo Carreño as Chief Technology OfficerPremier Graphene Inc. announces the appointment of visionary industry leader, Gustavo Carreño, as its new Chief Technology Officer (CTO). Mr. Carreño is poised to steer the Company into a future defined by innovation and transformative growth. With a proven track record at the forefront of technology-driven business evolution, the newly appointed CTO is primed to facilitate Premier Graphene’s foray into construction, oil & gas, and graphene manufacturing sectors with great expertise and strategic foresight. His experience serving as Managing Director for the Middle East and North Africa regions at Black Argentum LLC and CEO of Opulence Group, makes Gustavo uniquely qualified for this position. In these pursuits he cultivated invaluable connections between the Middle East and Latin America, unlocking lucrative cross-border opportunities in the oil & gas, commodity trading, and real estate development realms. This experience further enriches his strategic perspective, enabling him to identify and capitalize on synergies between industries and drive sustainable growth for Premier Graphene. Gustavo’s experience in revolutionizing operations through tech modernization and strategic initiatives underscores his ability to navigate complex business landscapes and implement innovative solutions tailored to industry needs. As Premier Graphene embarks on a journey of innovation and growth, the appointment of Gustavo as the new CTO signals a bold step towards a future defined by limitless possibilities. Premier Graphene eagerly anticipates the transformative impact of his leadership, as he works tirelessly to bring technological innovations to existing hemp-based graphene production while helping to explore these new very promising fields.
お知らせ • Jun 30Premier Biomedical, Inc. announced delayed 10-Q filingOn 06/29/2020, Premier Biomedical, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.